One of the largest private healthcare providers in Central Europe, Medicover, announced the launch of its fertility service in India today at Hotel Taj, New Delhi.
Medicover is going to be the first single Eurpoean family-owned organization to bring in 100% investment in healthcare delivery. The organization has a strong presence in Indian market with its established products like Oriflame cosmetics brand and other previous investments like Lotus surgical, thyrocare technologies, guardian pharmacy.
Speaking at the launch, Jonas A F Joschnick, Owner Medicover Group, Co-founder and Director, Oriflame Cosmetics said, “It gives us immense pleasure to bring in our expertise and our high-end quality and transparent services to Indian market. Being a world-class leader in most of specialized healthcare segment, we are committed to provide state-of-the-art technology and services to our patients by well-renowned doctors, clinicians, trained embroyologists and highly skilled fertility nurses.”
Talking about company’s plans and ever-growing IVF treatment market in India he further added, “We are all set to make our impact in the Indian market catering to the parental needs for all the couples having difficulty becoming parents. We plan to open over 50 fertility clinics and aim to earn $100 million in next three years. Initially, we are starting with 5 centers across Delhi-NCR, followed by more new centres to take the total to 10 by this year, covering most northern India. Eventually, we will expand to other parts of India including Punjab, Uttar Pradesh, Haryana, Uttarakhand, Maharashtra and Rajasthan in the coming years.”